Paul Smith
Presidente en Orasis Pharmaceuticals Ltd. .
Perfil
Paul Smith is currently the President & Chief Operating Officer at Orasis Pharmaceuticals Ltd.
Prior to this, he worked as the Executive Vice President-Commercial Operations at TearLab Corporation, Inc. from 2018 to 2019.
He also worked as a Manager at Alcon Laboratories, Inc. Mr. Smith completed his undergraduate degree at the University of Central Florida and earned an MBA from the University of Florida.
Cargos activos de Paul Smith
| Empresas | Cargo | Inicio |
|---|---|---|
Orasis Pharmaceuticals Ltd.
 Orasis Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Orasis Pharmaceuticals Ltd. operates as a clinical stage pharmaceutical company. It develops eye drops for the treatment of presbyopia as an alternative to reading glasses. The company was founded in 2015 and is headquartered in Herzliya, Israel. | Presidente | 26/04/2021 |
Antiguos cargos conocidos de Paul Smith.
| Empresas | Cargo | Fin |
|---|---|---|
| TEARLAB CORPORATION | Director de Operaciones | 01/06/2019 |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Corporate Officer/Principal | - |
Formación de Paul Smith.
| University of Central Florida | Undergraduate Degree |
| University of Florida | Masters Business Admin |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
TearLab Corporation, Inc.
 TearLab Corporation, Inc. Medical SpecialtiesHealth Technology TearLab Corporation, Inc. engages in the development and marketing of a tear testing platform. Its primary product, the TearLab Osmolarity System, enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It measures tear film osmolarity for the diagnosis of dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Escondido, CA. | Health Technology |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
Orasis Pharmaceuticals Ltd.
Orasis Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Orasis Pharmaceuticals Ltd. operates as a clinical stage pharmaceutical company. It develops eye drops for the treatment of presbyopia as an alternative to reading glasses. The company was founded in 2015 and is headquartered in Herzliya, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Paul Smith
